Assembly BillFailedHealth and Safety
AB 242: Genetic disease screening.
What AB 242 does, verified February 3, 2026
The bill aims to expand the state's newborn screening program to include Duchenne muscular dystrophy. The California Department of Public Health will establish a new screening process for this genetic disease, which will be implemented within a year. The costs of this expansion will be fully supported by fees paid for newborn screening tests. The bill also makes an appropriation to cover these costs.
Bill journey
✓IntroducedComplete
2In CommitteeCurrent
3First Chamber FloorPending
4Second ChamberPending
5GovernorPending
6ChapteredPending
Last action: From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. (2026-02-02)Alert me
Author and sponsors
Full contact details, staff, and committees with Connect, $15/moUnlockRecent actions9 total · showing 5
| Feb. 02, 2026 | From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. |
| Jan. 31, 2026 | Died pursuant to Art. IV, Sec. 10(c) of the Constitution. |
| May. 23, 2025 | In committee: Held under submission. |
| Apr. 23, 2025 | In committee: Set, first hearing. Referred to suspense file. |
| Apr. 02, 2025 | From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 15. Noes 0.) (April 1). Re-referred to Com. on APPR. |